Catalog Home Page

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology

Alter, J., Lou, F., Rabinowitz, A., Yin, H.F., Rosenfeld, J., Wilton, S.D., Partridge, T.A. and Lu, Q.L. (2006) Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nature Medicine, 12 (2). pp. 175-177.

Link to Published Version: http://dx.doi.org/10.1038/nm1345
*Subscription may be required

Abstract

For the majority of Duchenne muscular dystrophy (DMD) mutations, antisense oligonucleotide (AON)-mediated exon skipping has the potential to restore a functional protein. Here we show that weekly intravenous injections of morpholino phosphorodiamidate (morpholino) AONs induce expression of functional levels of dystrophin in body-wide skeletal muscles of the dystrophic mdx mouse, with resulting improvement in muscle function. Although the level of dystrophin expression achieved varies considerably between muscles, antisense therapy may provide a realistic hope for the treatment of a majority of individuals with DMD.

Publication Type: Journal Article
Publisher: Nature Publishing Group
Copyright: 2006 Nature Publishing Group
URI: http://researchrepository.murdoch.edu.au/id/eprint/21578
Item Control Page Item Control Page